Breast cancer: outcome audit of axillary management in 1991.
To audit the outcome of axillary treatment of patients diagnosed with invasive breast cancer in 1991, with particular reference to the incidence of regional recurrence and lymphoedema after limited axillary dissection. A review of records of patients identified prospectively. Two per cent regional recurrence and 5.7% lymphoedema incidence at 5 years. There is no indication from these results that axillary treatment, for our patient population, should be more aggressive.